Morgan Lewis Reps Perrigo In $540M Paddock Labs Buy

Law360, New York (January 20, 2011, 11:56 AM EST) -- Generic-drug and baby formula maker Perrigo Co. has agreed to shell out $540 million in cash for the assets of privately held generics company Paddock Laboratories Inc. as part of a larger effort to expand its drug portfolio.

Perrigo unveiled the deal Thursday, saying it expects to take home a hefty tax benefit of about $95 million from the purchase and predicting the transaction will add more than $200 million in sales during the first full fiscal year.

The deal is slated to close during the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.